New oncological therapies and the "right" price Authors Enrico Bosone Direttore Corporate Affairs and Market Access, Celgene srl, Milano - Italy DOI: https://doi.org/10.33393/grhta.2015.325
Downloads PDF (Italian) How to Cite Bosone, E. (2015). New oncological therapies and the "right" price. Global and Regional Health Technology Assessment, 2(1), 59–60. https://doi.org/10.33393/grhta.2015.325 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX Issue Vol. 2 No. 1 (2015): January-April 2015 Section Correspondence License Copyright (c) 2015 The authors This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Metrics Statistics Abstract views - 634 times PDF (Italian) downloads - 597 times Sign up Browse Sections Health Technology Assessment Health Policies banners150 0.8 2023CiteScore 28th percentile Powered by Completed peer reviews since:November 4, 2020 Most popular articles in the last 30 days Optimising pediatric paracetamol and ibuprofen use: a retrospective study with expert evaluation of efficacy, safety, and healthcare costs 367 Health technology assessment of an automated unitdose drug distribution system in a high-specialization national referral hospital of the Italian National Health Service 206 Differences in organizational impact, performance and quality related to the use of single- and/or reusable bronchoscopes in anesthesiology and resuscitation 125 Diagnostic and therapeutic approach to the ACS patient 107 The socioeconomic burden of adult attention-deficit/hyperactivity disorder in Spain 102